Dual specificity mitogen-activated protein (MAP) kinase phosphatase-4 plays a potential role in insulin resistance

Haiyan Xu1, Marlene Dembski, Qing Yang

  • 1Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, USA. haiyan.xu@mpi.com

Insights

Mitogen-activated dual specificity protein kinase phosphatase 4 (MKP-4) was identified as a gene that negatively regulates insulin signaling. Upregulated MKP-4 in obesity may contribute to insulin resistance and type 2 diabetes development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Endocrinology

Background:

  • Insulin regulates glucose homeostasis; its dysregulation causes diabetes mellitus, with type 2 diabetes linked to obesity.
  • Obesity-induced insulin resistance is a major contributor to type 2 diabetes pathogenesis.
  • Novel protein targets are needed to understand and treat obesity-related insulin resistance.

Purpose of the Study:

  • To identify novel proteins involved in obesity-related insulin resistance and type 2 diabetes.
  • To screen for genes that negatively regulate insulin signaling pathways.

Main Methods:

  • A functional expression screen using a reporter system (PEPCK promoter driving alkaline phosphatase) in hepatocytes.
  • Screening of a cDNA library from white adipose tissue of ob/ob mice (a model of insulin resistance).
  • Assessing MKP-4 expression and its functional impact on adipogenesis and glucose uptake in rodent models and cell cultures.

Main Results:

  • Mitogen-activated dual specificity protein kinase phosphatase 4 (MKP-4) was identified as a candidate gene.
  • MKP-4 is expressed in insulin-responsive tissues and upregulated in obese, insulin-resistant rodent models.
  • Overexpression of MKP-4 inhibited insulin-induced adipogenesis and insulin-stimulated glucose uptake.

Conclusions:

  • MKP-4 negatively regulates insulin signaling.
  • MKP-4 may play a significant role in the pathogenesis of insulin resistance and type 2 diabetes.
  • MKP-4 represents a potential therapeutic target for metabolic disorders.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...